The application value of quantitative parameters MR FDGmax and SUV max in the stages of hepatitis, liver fibrosis and cirrhosis in rats by whole-body dynamic 18 F-FDG PET/CT Patlak imaging

Acta Universitatis Medicinalis Anhui 2024 04 v.59 230-235     font:big middle small

Found programs:

Authors:Shi Huimin; Zhang Jinzhou; Wang Xin; Zhu Gan; Zhao Xuefeng; Wang Hui

Keywords:whole-body dynamic PET/CT;Patlak;MR ;SUV ;Hepatitis;liver fibrosis;cirrhosis

DOI:10.19405/j.cnki.issn1000-1492.2024.02.008

〔Abstract〕 Objective To investigate the application value of quantitative parameters MRFDGmaxand SUVmaxin the stages of hepatitis, liver fibrosis and cirrhosis in rats by whole-body dynamic18F-FDG PET/CT Patlak imaging. Methods Twenty-four SD rats were randomly divided into four groups of six rats each, which were the normal group, hepatitis group, liver fibrosis group and cirrhosis group. According to the experimental grouping, rats in each group were induced by the CCl4oil solution complex method. Whole-body dynamic18F-FDG PET/CT patlak imaging was performed on each group of rats separately at the completion of induction.After the imaging was completed, the MRFDGmax, SUVmaxand CT values of the livers of each group were analyzed; subsequently, the serum of rats in each group was extracted for the detection of liver function indexes(AST, ALT and ALP), and HE staining was performed on the livers of rats in the normal, hepatitis and cirrhosis groups, and Masson staining was performed on those in the liver fibrosis group; the α-SMA expression in the liver tissues of each group was analyzed by immunohistochemical method. The data were analyzed by one-way ANOVA, two independent samples t-test and Pearson correlation analysis. Results MRFDGmax, SUVmaxvalues were statistically significant differences among normal, hepatitis, liver fibrosis and cirrhosis groups(F=84.54, 38.35,P<0.001). The difference in CT values between liver fibrosis and cirrhosis groups was not statistically significant(t=-0.407,P=0.693), and the difference was statistically significant when compared between the rest of the groups(F=112.25,P<0.001). Compared with the normal group, AST, ALT and ALP of the experimental group showed a staged increase, and the differences were statistically significant(F=93.32, 64.63, 145.03,P<0.001). HE staining showed that hepatocytes of the normal group were neatly arranged and structurally intact; a large number of inflammatory cells infiltrated the hepatitis group with steatosis; pseudo lobe formation was observed in the cirrhosis group. Masson staining of the liver fibrosis group showed collagen fiber proliferation and thickening of the peritoneum. Immunohistochemistry test results showed that α-SMA expression increased in hepatitis group, liver fibrosis group and cirrhosis group, with a staged increase, and the difference was statistically significant(F=80.57,P<0.001). Correlation analysis showed a positive correlation between SUVmaxand MRFDGmax(r=0.967,P<0.01). α-SMA was positively correlated with AST, ALT and ALP in the hepatitis, liver fibrosis and cirrhosis groups, respectively(r=0.924, 0.756, 0.934,P<0.01). Conclusion Whole-body dynamic18F-FDG PET/CT Patlak imaging has application value in monitoring hepatitis, liver fibrosis and cirrhosis stages through quantitative parameters MRFDGmaxand SUVmaxchanges.